Pharma channel feed

Sen. Cas­sidy ques­tions Lil­ly and Am­gen on 340B re­stric­tions on con­tract phar­ma­cies

8 months ago
Law

UCB adds three more FDA ap­provals to la­bel for po­ten­tial block­buster Bimzelx

8 months ago
FDA+

Is Sanofi mak­ing a move in­to obe­si­ty? French phar­ma in­vests $27M in­to Ven­tyx

8 months ago
Deals

Sanofi's Sar­clisa gets ap­proved as a first-line op­tion for some pa­tients new­ly di­ag­nosed with mul­ti­ple myelo­ma

8 months ago
FDA+

The drug lob­by's law­suit against the IRA finds a sign of life af­ter ap­peals court rul­ing

8 months ago
Law

Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?

8 months ago
Health Tech

FDA OKs the first-ever self-ad­min­is­tered vac­cine, for flu

8 months ago
FDA+

FTC to sue ma­jor PBMs over in­sulin re­bates, claim­ing they in­flat­ed pa­tient cost

8 months ago
Law

Up­dat­ed: FDA ap­proves Zevra’s rare dis­ease drug af­ter re­sub­mis­sion

8 months ago
FDA+

No­vo ax­es Phase 2 of For­ma-ac­quired drug in myelodys­plas­tic syn­dromes

8 months ago
R&D

Sanofi's BTK in­hibitor again slows MS pro­gres­sion, but liv­er en­zymes con­tin­ue to be tricky

8 months ago
R&D

FDA in­spec­tors dis­cov­er trucks car­ry­ing torn-up records leav­ing In­di­an gener­ics fac­to­ry

8 months ago
FDA+
Manufacturing

FDA re­jects Van­da’s treat­ment for di­ges­tion con­di­tion, com­pa­ny re­bukes agen­cy's ac­tions

8 months ago
FDA+

FDA ap­proves As­traZeneca’s asth­ma med­ica­tion Fasen­ra to treat rare au­toim­mune con­di­tion

8 months ago
FDA+

Here's what to­day's Fed rate cut means for biotech, phar­ma and ven­ture cap­i­tal

8 months ago

Keytru­da adds new FDA ap­proval for a rare form of mesothe­lioma

8 months ago
R&D

Sen­a­tors tell FDA that ‘greater ac­tion is need­ed’ to use man­u­fac­tur­ing tech in US sup­ply chains

8 months ago
FDA+
Manufacturing

Ther­at­e­ch­nolo­gies' HIV drug to face sup­ply is­sues in 2025 over third-par­ty fa­cil­i­ty shut­down 

8 months ago
FDA+
Manufacturing

No­var­tis’ Kisqali snags FDA ap­proval to re­duce re­cur­rence in pa­tients with ear­ly forms of breast can­cer

8 months ago
FDA+

CD­MO Serán sets out to build first com­mer­cial fa­cil­i­ty, with a $200M in­vest­ment led by Bain Cap­i­tal

8 months ago
Manufacturing

Co­herus warns of lim­it­ed can­cer drug sup­ply due to third-par­ty ‘ca­pac­i­ty con­straints’

8 months ago
Manufacturing

Cigna sues FTC, call­ing for with­draw­al of 'bi­ased, er­ro­neous' PBM re­port

8 months ago
Law
Health Tech

Sun, sur­pris­es and new sum­mits at Eu­rope’s biggest can­cer con­fer­ence

8 months ago
R&D

Af­ter land­ing a key win in a com­mon can­cer con­di­tion, Pfiz­er faces a big test in Phase 3

8 months ago
R&D
First page Previous page 35363738394041 Next page Last page
A service from the Financial Times